Cerebrovascular Lesions in Down Syndrome Do Not Follow a Linear Course

by Hospital de la Santa Creu i Sant Pau

A longitudinal study from the Institut de Recerca Sant Pau (IR Sant Pau), published in Alzheimer’s & Dementia, shows that these alterations can fluctuate and even decrease over time in the Down synd...

Read more

Researchers from IRBLleida and the Vall d'Hebron Institute of Research identify several cases of a rare disease transmitted by a sperm donor

by IRB Lleida. Institut de Recerca Biomèdica

The research describes the world's first documented case of transmission of hereditary angioedema through assisted reproduction

Read more

A Clinical Trial Investigates Whether Preventing Epilepsy Can Slow Alzheimer’s Disease in People With Down Syndrome

by Hospital de la Santa Creu i Sant Pau

The LESS-AD study is based on a novel therapeutic hypothesis: administering levetiracetam preventively, before the first epileptic seizure occurs, could not only reduce the risk of seizures but also h...

Read more

La FDA aprueba en Estados Unidos el primer medicamento de terapia génica desarrollado a partir de una investigación española

by CIBERER - Centro de Investigación Biomédica en Red de Enfermedades Raras

La Agencia Estadounidense de Alimentos y Medicamentosha aprobado el medicamento de terapia génica denominado KRESLADI™ (marnetegragene autotemcel) de la empresa Rocket Pharma para el tratamiento de...

Read more

A new genomic technique reveals a previously undetectable genetic alteration in hereditary angioedema

by Vall d’Hebron

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventio...

Read more

A study expands the genetic basis of an encephalopathy associated with epilepsy and autism

by Universitat de Barcelona

A multicentre study describes the wide variability in clinical symptoms among patients and reveals that the severity of the disease does not depend exclusively on the SYNGAP1 gene, but on other geneti...

Read more

Las mutaciones de novo explican casos graves de deficiencia de antitrombina sin antecedentes familiares

by Universidad de Murcia

Demuestran el papel relevante de las mutaciones de novo en la deficiencia de antitrombina, una enfermedad genética rara causada por alteraciones en el gen SERPINC1 que incrementa significativamente e...

Read more

Un nuevo decálogo establece las claves para mejorar el diagnóstico y tratamiento del déficit de alfa-1 antitripsina

by INCLIVA

Un artículo reciente publicado en la revista científica Open Respiratory Archives presenta un decálogo de prioridades para mejorar el diagnóstico y el tratamiento del déficit de alfa-1 antitripsi...

Read more

Parc Taulí is looking for adult men with fragile X syndrome to participate in a clinical trial of a new drug

by Instituto de Investigación e Innovación Parc Taulí

A research team from the Parc Taulí Research and Innovation Institute (I3PT) is looking for adult men with fragile X syndrome to participate in a phase II clinical trial. The study aims to evaluate t...

Read more

Neumólogos del Hospital público Clínico San Carlos identifican una nueva variante genética en el déficit de alfa 1 antitripsina

by Hospital Universitario Clínico San Carlos

Han identificado una nueva variante genética del déficit de Alfa 1 Antitripsina, una enfermedad genética minoritaria que aumenta los riesgos de sufrir enfermedades respiratorias y hepáticas

Read more

A study co-led by IDIBGI identifies the origin of sleep disorders in FOXP1 syndrome

by IdiBGi

The results indicate that genes of the FOXP family are essential during the development of the nervous system to ensure a normal sleep pattern in adulthood.

Read more

Together with Patients with Duchenne, IBEC is developing a ‘heart-on-a-chip’ to halt the cardiac damage caused by the condition

by IBEC - Institut de Bioenginyeria de Catalunya

Duchenne Parent Project Spain has invested €247,000 in the BEAT project, which will be carried out by IBEC. Cardiomyopathy is the leading cause of death in patients with Duchenne muscular dystrophy...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Researchers Discover How Acute Myeloid L...

by Institut de Recerca Sant Pau

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...

Photos Stream